Do Checkpoint Inhibitors Compromise the Cancer Patients’ Immunity and Increase the Vulnerability to COVID-19 Infection?

Immunotherapy - United Kingdom
doi 10.2217/imt-2020-0077
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd


Related search